Successful treatment of diffuse large b-cell lympoma following waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab

Keita Uchino, Hidekazu Sameshima, Toshihiro Miyamoto, Tadafumi Iino, Koji Kato, Hideho Henzan, Ken Ichi Aoki, Koji Nagafuji, Hisashi Gondo, Mine Harada

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

We report a 72-year-old man with Waldenström's macroglobulinemia (WM) in whom diffuse large B-cell lymphoma (DLCL) occurred 17 years after the diagnosis of WM. The malignant cells of both DLCL and WM expressed CD20 on their surface. CHOP plus anti-CD20 monoclonal antibody, rituximab, were effective for both diseases, and the patient remains disease-free 17 months later.

Original languageEnglish
Pages (from-to)131-134
Number of pages4
JournalInternal Medicine
Volume43
Issue number2
DOIs
Publication statusPublished - Feb 2004

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Successful treatment of diffuse large b-cell lympoma following waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab'. Together they form a unique fingerprint.

Cite this